Geron
GERN
#6695
Rank
NZ$1.45 B
Marketcap
NZ$2.27
Share price
-0.37%
Change (1 day)
6.88%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -NZ$60.93 Million

According to Geron's latest financial reports the company's current earnings are NZ$0.19 Billion. In 2025 the company made an earning of -NZ$88.29 Million, an increase over its 2024 earnings that were of -NZ$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$60.93 Million-30.99%
2025 -NZ$88.29 Million-67.42%
2024 -NZ$0.28 Billion-11.23%
2023 -NZ$0.31 Billion30.22%
2022 -NZ$0.24 Billion20.15%
2021 -NZ$0.2 Billion50.08%
2020 -NZ$0.14 Billion4.46%
2019 -NZ$0.13 Billion130.68%
2018 -NZ$53.96 Million8.84%
2017 -NZ$49.58 Million-3.08%
2016 -NZ$51.15 Million-22080.6%
2015 NZ$0.23 M-100.38%
2014 -NZ$61.8 Million-7.14%
2013 -NZ$66.55 Million
2011 -NZ$0.16 Billion19.04%
2010 -NZ$0.14 Billion8.45%
2009 -NZ$0.13 Billion-2.51%
2008 -NZ$0.13 Billion14.65%
2007 -NZ$0.11 Billion32.68%
2006 -NZ$82.25 Million25.59%
2005 -NZ$65.49 Million4.36%
2004 -NZ$62.75 Million19.73%
2003 -NZ$52.41 Million-15.46%
2002 -NZ$62 Million1.94%
2001 -NZ$60.82 Million33.59%
2000 -NZ$45.52 Million27.53%
1999 -NZ$35.7 Million63.13%
1998 -NZ$21.88 Million15.6%
1997 -NZ$18.93 Million-10.66%
1996 -NZ$21.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$18.62 B-30,147.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$3.08 B-5,068.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$0.13 Billion 93.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.27 B-539.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$25.91 Million-58.22%๐Ÿ‡บ๐Ÿ‡ธ USA